Drawing for DRUGMET

USPTO serial 79003219

DRUGMET

Reviewed by CopyMark Law Group

Reg. 3006050Status 404
Filing date
Status date
Registration date
Oct 11, 2005
Examiner
LOTT, JASON E
Law office
POST REGISTRATION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DRUGMET?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James M. Slattery

JAMES M SLATTERY BIRCH, STEWART, KOLASCH & BIRCH LLPPO BOX 747FALLS CHURCH, VA 22040-0747UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Analytical and diagnostic kits comprising chemical reagents, microarray chips and software for genotyping, detection of polymorphisms in human beings and determination of genetic basis of drug response, all for use in testing of clinical samples in drug development and pharmaceutical research; software for the data analysis of nucleic acid, protein and molecule information and for the translation of such data into genotyping information; apparatus for use in clinical trials of drug development, and research, namely microarray chipsSECTION 71 - CANCELLED—
010Medical apparatus and instruments, namely, dna microarray, dna test comprised of test kit consisting of microarray, reagent package and genotyping software for assessing predisposition to risks of cardiovascular, metabolic/endocrinological, respiratory, gastrointestinal, psychiatric, neurological, ophthalmological and musculoskeletal diseases and cancers, and for predicting individual susceptibilities and response to therapeutic and nutritional interventionsSECTION 71 - CANCELLED—
042Scientific, clinical and diagnostic services, namely genotyping; detection of mutations and polymorphisms in human beings, determination of the genetic basis of drug response; doing analysis and providing the genotype data in electronic or paper formatSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 7, 2014INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Oct 30, 2014DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Oct 30, 2014DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 17, 2014INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Apr 30, 2014INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Aug 30, 2013C71TCANCELLED SECTION 71—
Aug 31, 2007FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 13, 2006FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 13, 2006FIMPFINAL DISPOSITION PROCESSED—
Jun 19, 2006FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 19, 2005LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Oct 11, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 19, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 29, 2005NPUBNOTICE OF PUBLICATION—
Apr 13, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 8, 2005ALIEASSIGNED TO LIE—
Apr 2, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 1, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Mar 18, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 18, 2005MAILPAPER RECEIVED—
Dec 16, 2004RFNTREFUSAL PROCESSED BY IB—
Nov 18, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 8, 2004CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 28, 2004DOCKASSIGNED TO EXAMINER—
Jul 19, 2004NWAPNEW APPLICATION ENTERED—
Jul 15, 2004REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance